Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Cureus ; 16(2): e54709, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38524077

ABSTRACT

Background This study aimed to examine the factors predicting participants' intention to use telemedicine during the COVID-19 pandemic. Interest in health information technologies (HITs) has increased due to COVID-19. Most studies have focused on the acceptance of HIT by physicians and nurses, while there is a lack of studies on patients' perception and acceptance of such systems in ophthalmology. Methodology In the first year of the COVID-19 pandemic, a survey comprising 19 items was conducted at an ophthalmic center in Greece. The participants included 77 patients diagnosed with various eye diseases. The survey aimed to evaluate variables related to the Technology Acceptance Model (TAM), such as perceived usefulness, perceived ease of use, facilitating conditions, and intention to use telemedicine. The statistical analyses included intercorrelations, internal consistency reliability tests, and multiple linear regression analysis to examine the predictors of intention to use telemedicine. Results The multiple linear regression analysis revealed that perceived usefulness and facilitating conditions emerged as significant predictors of eye patients' intentions to use HIT. Interestingly, while perceived ease of use did not exhibit a significant predictive relationship with use intentions, the influence of perceived usefulness and facilitating conditions within the healthcare context underscores the pivotal role of perceived utility and external support in shaping patients' willingness to engage with HIT for eye care. Conclusions Empirical data on patient acceptance offer a better understanding of the limiting factors and the variables that facilitate intentions to use services that may improve medical diagnoses, patient communication, and treatment adherence processes. Related interventions and communication efforts should highlight the benefits of HIT in ophthalmology and provide the appropriate support and means to facilitate its use during and after the pandemic.

2.
Cureus ; 14(12): e32796, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36694530

ABSTRACT

Background In this study, we aimed to assess the safety and efficacy of hypertonic sodium chloride 5% ointment in the treatment of recurrent corneal erosion syndrome (RCES). Methodology A total of 21 eyes from 21 patients with RCES either following trauma or spontaneously due to underlying anterior basement membrane dystrophy (ABMD) were prospectively enrolled over a six-month period. The acute episode was managed with topical sodium chloride 5% ophthalmic ointment applied twice daily for 30 days. Patients were followed up at one month and six months with visual acuity and endothelial cell count (ECC) measurement. Results The mean age was 44.19 years (range = 17-87 years). All patients had unilateral involvement. The etiology was ABMD in 12 cases, while nine cases were post-traumatic. The mean best-corrected visual acuity (BCVA) at presentation was 0.32 logMAR units (SD = 0.18), and the mean ECC before treatment initiation was 2,720 cells/mm2 (SD ± 192). At the one-month follow-up, all patients had a full recovery with complete re-epithelization of the defective area and resolution of symptoms. The mean BCVA was 0.05 logMAR units (SD = 0.12), and the mean ECC was 2,703 cells/mm2 (SD = 205). At six months, only one recurrence was documented following another episode of trauma. The mean BCVA and ECC at six months were 0.01 logMAR units and 2,714 cells/mm2, respectively. Conclusions Sodium chloride 5% ophthalmic ointment applied twice daily for 30 days following the acute event seems to be a safe and effective treatment option for RCES from both traumatic and ABMD etiology.

SELECTION OF CITATIONS
SEARCH DETAIL
...